Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells. Others are finding ways to boost the body’s own immune system to attack cancer cells. For the first time, researchers at Penn State have combined the two approaches by conjugating biodegradable polymer nanoparticles encapsulated with chosen cancer-fighting drugs into immune cells to create a smart, targeted system to attack cancers of specific types.
“The traditional way to deliver drugs to tumors is to put the drug inside some type of nanoparticle and inject those particles into the bloodstream,” said Jian Yang, professor of biomedical engineering, Penn State. “Because the particles are so small, if they happen to reach the tumor site they have a chance of penetrating through the blood vessel wall because the vasculature of tumors is usually leaky.”
The odds of interacting with cancer cells can be improved by coating the outside of the nanoparticles with antibodies or certain proteins or peptides that will lock onto the cancer cell when they make contact. However, this is still a passive drug delivery technology. If the particle does not go to the tumor, there is no chance for them to bind and deliver the drug.
Yang and Cheng Dong, department head and distinguished professor of biomedical engineering, wanted a more active method of targeting drugs to the cancer wherever it was located, whether circulating in the blood, or in the brain or in any of the other organs of the body.
“I have 10 years of working in immunology and cancer,” Dong said. “Jian is more a biomaterials scientist. He knows how to make the nanoparticles biodegradable. He knows how to modify the particles with surface chemistry, to decorate them with peptides or antibodies. His material is naturally fluorescent, so you can track the particles at the same time they are delivering the drug, a process called theranostics that combines therapy and diagnostics. On the other hand, I study the cancer microenvironment, and I have discovered that the microenvironment of the tumor generates kinds of inflammatory signals similar to what would happen if you had an infection.”
Immune cells, which were built to respond to inflammatory signals, will be naturally attracted to the tumor site. This makes immune cells a perfect active delivery system for Yang’s nanoparticles. The same technology is also likely to be effective for infectious or other diseases, as well as for tissue regeneration, Dong said.
In the first proof of their technology, the two research groups targeted circulating melanoma cells. In a paper published in the current online issue of the journal Small, titled “Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting,” the researchers report the use of a novel biodegradable and photoluminescent poly (lactic acid) (BPLP-PLA) nanoparticle, loaded with melanoma-specific drugs with immune cells as the nanoparticle carriers. They showed that the immune cells could bind to the melanoma cells under shear stress conditions similar to those in the bloodstream. These experiments were all performed outside the body. Next they intend to perform studies in animal models and in solid tumors.
“This is the first study and is just to show that the technology works,” Dong said. “This study is not about curing melanoma. There are probably other ways to do that. We used melanoma cells to validate the approach.”
Receive an email update when we add a new DRUG DELIVERY article.
The Latest on: Nanoparticle drug delivery
via Google News
The Latest on: Nanoparticle drug delivery
- Aphios Granted US Patent For Combination HIV Latency Nanotherapeutic Towards an HIV Cureon January 28, 2020 at 8:24 am
Aphios granted US Patent for combination nanoparticle therapeutic for the treatment of HIV latency towards an HIV cure ...
- New Drug Delivery Systems Market And Top Key Players are 3M Company, Abbott Laboratories Ltd., Amgen Inc.on January 28, 2020 at 6:52 am
The largest revenue share in this market is set to be attained by the nanoparticles segment. The following are the advantages related with nanoparticles as opposed to traditional drug delivery system ...
- Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agenton January 28, 2020 at 2:17 am
Since the discovery of metal nanoparticles (NPs) in the 1960s, unknown toxicity ... These in vivo-generated metal NPs represent a biocompatible drug delivery platform for chemotherapy resistant tumor ...
- New Drug Delivery Systems Market Trends, Outlook, Opportunity Till 2022on January 26, 2020 at 10:45 pm
Novel Drug Delivery System (NDDS) involves the prompt and efficient provision of the prescribed or therapeutic amount ...
- Nanoparticle Therapy Shows Promise with Breast Canceron January 24, 2020 at 5:55 am
The surface of the nanoparticles also was coated with polyethylene glycol to keep them circulating through the bloodstream and lymph system until they reached the tumor and to prevent them from being ...
- Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.on January 23, 2020 at 11:00 am
Hollow mesoporous silica microsphere (HMSM) particles are one of the most promising vehicles for efficient drug delivery owing to their large hollow interior cavity ... approach to produce HMSM ...
- Science Revolution Sparked by Rapid Progress in Nanotechnologyon January 21, 2020 at 11:11 am
“It is crucial to increase the efficiency of drugs and to reduce side effects, and this is something that can be achieved with on-command drug delivery,” said Mr. Ohnoutek. “By illuminating metal ...
- Midatech Pharma sees big 18 months ahead as clinical trials build momentumon January 17, 2020 at 4:05 pm
R&D company Midatech is developing a range of improved chemo-therapies and new immuno-therapeutics using its trio of drug delivery platforms. Each of the technologies is focused ... MidaCore is the ...
- Nano-silicon Drug Delivery Platform Market Worldwide Major Trend Outlook 2019 to 2027on January 17, 2020 at 2:23 am
Porous silicon nanoparticles are used in medical applications as drug delivery devices, owing to their high biocompatibility, surface area, and biodegradability. This has driven the nano-silicon drug ...
via Bing News